Quest Diagnostics Incorporated (DGX) To Go Ex-Dividend on January 13th

Quest Diagnostics Incorporated (NYSE:DGX) announced a quarterly dividend on Tuesday, November 11th. Stockholders of record on Tuesday, January 13th will be given a dividend of 0.80 per share by the medical research company on Wednesday, January 28th. This represents a c) dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, January 13th.

Quest Diagnostics has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 14 consecutive years. Quest Diagnostics has a payout ratio of 30.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Quest Diagnostics to earn $10.49 per share next year, which means the company should continue to be able to cover its $3.20 annual dividend with an expected future payout ratio of 30.5%.

Quest Diagnostics Stock Down 1.0%

Shares of DGX stock opened at $187.04 on Thursday. The stock’s fifty day moving average price is $182.75 and its 200 day moving average price is $178.11. Quest Diagnostics has a 1-year low of $148.70 and a 1-year high of $197.55. The company has a market cap of $20.81 billion, a price-to-earnings ratio of 21.95, a price-to-earnings-growth ratio of 2.31 and a beta of 0.58. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.13 and a quick ratio of 1.04.

Quest Diagnostics (NYSE:DGX) last issued its quarterly earnings results on Tuesday, October 21st. The medical research company reported $2.60 earnings per share for the quarter, topping analysts’ consensus estimates of $2.51 by $0.09. The business had revenue of $2.82 billion for the quarter, compared to analyst estimates of $2.73 billion. Quest Diagnostics had a return on equity of 15.47% and a net margin of 8.91%.The company’s revenue was up 13.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.30 earnings per share. Quest Diagnostics has set its FY 2025 guidance at 9.760-9.840 EPS. On average, research analysts expect that Quest Diagnostics will post 9.7 earnings per share for the current fiscal year.

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.